Recurrence Predictor Test
Hi all, This just came up in my Facebook feed and it sounds like an amazing development, that hopefully isn't too far away - scientists at Cambridge and Stanford Universities have developed a tool ...
Forum Discussion
@kezmusc There was quite a bit about the protective role of progesterone in breast cancer in the Garvan presentation. It is being looked at quite carefully.
I took quite a lot of notes but it's dense scientific stuff and I haven't had the time or energy to summarise it yet.
However I do recall the professor saying that making progesterone is difficult and expensive and the French are the only ones who do it. Progestins were used in HRT. Previously thought to be the same, they're not, but progesterone got swept away in the controversy. The scientific community has circled back and are looking closely at it.
They think that possibly one of the reasons that BC rates rise after menopause is because progesterone declines.
This is one of the slides they showed us:
So there are trials going on at the moment about adding it back in. This is the Garvan one:
I took quite a lot of notes but it's dense scientific stuff and I haven't had the time or energy to summarise it yet.
However I do recall the professor saying that making progesterone is difficult and expensive and the French are the only ones who do it. Progestins were used in HRT. Previously thought to be the same, they're not, but progesterone got swept away in the controversy. The scientific community has circled back and are looking closely at it.
They think that possibly one of the reasons that BC rates rise after menopause is because progesterone declines.
This is one of the slides they showed us:
So there are trials going on at the moment about adding it back in. This is the Garvan one: